| OSMCX | WIIGX | OSMCX / WIIGX | |
| Total Expense Ratio | 2.13 | 1.36 | 157% |
| Annual Report Gross Expense Ratio | 2.13 | 1.38 | 154% |
| Fund Existence | 28 years | 10 years | - |
| Gain YTD | 2.732 | -0.133 | -2,058% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 100000 | 1% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.56B | 171M | 1,496% |
| Annual Yield % from dividends | 0.83 | 0.00 | - |
| Returns for 1 year | -6.51 | -29.93 | 22% |
| Returns for 3 years | -18.78 | -38.77 | 48% |
| Returns for 5 years | -38.65 | -57.91 | 67% |
| Returns for 10 years | -4.86 | -44.81 | 11% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AIVOX | 12.83 | 0.18 | +1.42% |
| American Century International Opps A | |||
| VSFCX | 23.42 | 0.07 | +0.30% |
| Federated Hermes MDT Small Cap Value C | |||
| JFNIX | 81.99 | -0.52 | -0.63% |
| Janus Henderson Global Life Sciences I | |||
| RYEUX | 128.58 | -1.83 | -1.40% |
| Rydex Europe 1.25x Strategy H | |||
| SLRYX | 41.66 | -0.67 | -1.58% |
| SEI Large Cap Growth Y (SIMT) | |||